Search

Pharming Group NV

Ouvert

0.824 -1.44

Résumé

Variation du prix de l'action

24h

Actuel

Min

0.827

Max

0.836

Chiffres clés

By Trading Economics

Revenu

6.7M

1.6M

Ventes

19M

90M

P/E

Moyenne du Secteur

87.5

48.735

BPA

0.002

Marge bénéficiaire

1.744

Employés

407

EBITDA

7.1M

5M

Dividendes

By Acuity

Prochains Résultats

5 nov. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-179M

619M

Ouverture précédente

2.26

Clôture précédente

0.824

Pharming Group NV Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

18 oct. 2026, 23:51 UTC

RBA's Assistant Governor Kent addresses interest rates amid rising inflation and global market pressures, signaling cautious investor sentiment.

18 oct. 2026, 23:51 UTC

China's Q3 GDP Growth Forecast at +1.1% Amid Mixed Economic Sentiment and Global Challenges

18 oct. 2026, 23:51 UTC

Bank of Korea Expected to Maintain 3% Interest Rate Amid Inflation and Economic Growth Concerns

18 oct. 2026, 23:51 UTC

NAHB Housing Market Index Expected to Drop to 31.0 Amid Declining Builder Sentiment and Economic Pressures Ahead of October Release.

18 oct. 2026, 23:41 UTC

China's Q3 2026 GDP Growth Rate Expected to Rise Slightly to 4.4% Amidst Cautious Optimism and Economic Challenges

18 oct. 2026, 23:41 UTC

Canada's Retail Sales Ex Autos Expected to Rise 1.2% MoM for August Amid Mixed Economic Sentiment

18 oct. 2026, 23:41 UTC

China's Retail Sales Expected to Rise 0.5% YoY in September Amidst Cautious Economic Sentiment, Release Scheduled for October 19, 2026

18 oct. 2026, 23:41 UTC

China's Industrial Production YoY data for September 2026 is set to release on October 19, with a forecast growth of 5.4%, reflecting cautious optimism in the market amid potential impacts on PBOC monetary policy.

18 oct. 2026, 23:41 UTC

China's Fixed Asset Investment Expected to Decline by -7.3% YoY, Raising Market Concerns Ahead of Key Economic Data Release on October 19, 2026

18 oct. 2026, 23:32 UTC

News

Arthur Hayes stated on social media that quantum computing should not deter Bitcoin investment and cautioned against the security risks of reusing wallet addresses.

18 oct. 2026, 23:32 UTC

Macro News
News

Bitcoin is trading modestly higher, with Arthur Hayes noting that quantum computing concerns shouldn't deter investors from holding the asset.

18 oct. 2026, 23:31 UTC

Correlated Moves
Macro News

Prices rise amid higher crude oil and geopolitical tensions.

18 oct. 2026, 23:31 UTC

Correlated Moves

XRP is advancing, reflecting a broader upward movement in the cryptocurrency space, as Bitcoin has also gained slightly since the previous close.

18 oct. 2026, 23:21 UTC

China's Loan Prime Rate Expected to Hold Steady at 3.0% Amid Economic Uncertainties Ahead of October 20 Announcement

18 oct. 2026, 23:21 UTC

China's Loan Prime Rate Expected to Hold at 3.5% Amid Mixed Economic Signals and Geopolitical Tensions

18 oct. 2026, 23:11 UTC

China's House Price Index YoY release on October 19, 2026, shows ongoing housing market challenges with a previous decline of -3.0%, as analysts watch for potential stabilization from recent government interventions amid cautious investor sentiment.

18 oct. 2026, 23:01 UTC

The EUR/CZK is trading roughly flat as macroeconomic challenges and inflation data raise concerns about potential interest rate hikes by the Federal Reserve.

18 oct. 2026, 23:01 UTC

Macro News
Correlated Moves

The Nasdaq 100 Index is modestly higher, supported by a $5 billion U.S. initiative to enhance power line capacity amid rising electricity demand.

18 oct. 2026, 23:01 UTC

Macro News
Correlated Moves

Silver is modestly higher as tensions between Ukraine and Russia escalate, impacting global energy markets, while Gold remains little changed amid ongoing gains.

18 oct. 2026, 23:01 UTC

Macro News

Platinum prices are lower amid geopolitical tensions from Ukrainian drone strikes and the U.S. Energy Department's $5 billion initiative affecting energy supply dynamics.

18 oct. 2026, 23:01 UTC

Correlated Moves
Macro News

The U.S. Energy Department announced a $5 billion initiative to enhance power line capacity across 26 states, boosting grid efficiency amid rising electricity demand.

18 oct. 2026, 23:01 UTC

Macro News

Natural gas prices are declining, continuing a downward trend amid geopolitical tensions and rising U.S. fuel costs, with prices below the 20-day moving average.

18 oct. 2026, 23:01 UTC

Macro News

Oil prices are declining as the U.S.-Iran conflict impacts global markets, contributing to rising fuel costs, with gasoline averaging $4.33 per gallon.

18 oct. 2026, 23:01 UTC

Correlated Moves
Macro News

The Russell 2000 Index is higher amid concerns over inflation and potential Fed interest rate hikes, alongside a $5 billion U.S. energy initiative.

18 oct. 2026, 23:01 UTC

The EUR/CHF currency pair is trading lower as the new week begins, influenced by concerns over potential Federal Reserve interest rate hikes amid rising inflation.

18 oct. 2026, 23:01 UTC

The GBP/AUD is trading modestly lower as the new trading week begins, following a retracement from an early peak amid broader market concerns.

18 oct. 2026, 23:01 UTC

The EUR/NZD is declining in early trading, influenced by higher-than-expected inflation data and concerns over potential Federal Reserve interest rate hikes.

18 oct. 2026, 23:01 UTC

The EUR/JPY is trading modestly lower as the new trading week begins, following a notable decline and concerns over potential Fed interest rate hikes.

18 oct. 2026, 23:01 UTC

The EUR/AUD is trading lower at the start of the new week, continuing Friday's decline amid concerns over inflation and potential interest rate hikes.

18 oct. 2026, 23:01 UTC

GBP/CAD is lower as trading resumes for the week, influenced by recent inflation data raising concerns over potential Federal Reserve interest rate hikes.

Comparaison

Variation de prix

Pharming Group NV prévision

Note du Consensus

By TipRanks

0 ratings

0

Achat

0

Maintien

0

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Pharming Group NV

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
help-icon Live chat